Clinical Study
A Postauthorization Survey to Document the Therapeutic Management of Oxaliplatin as a First-Line Chemotherapy Regimen in South Africa in Patients with Metastatic Colorectal Cancer
Table 3
Reasons for discontinuation of treatment with oxaliplatin.
| ||||||||||||||||||||||||
The percentage is calculated out of 195, the total number of patients in the survey’s cohort. |